144 related articles for article (PubMed ID: 18796503)
1. Data analysis and interpretation of results in DATAS trial.
Vardanyan Z; Kanna B
Europace; 2008 Oct; 10(10):1243; author reply 1243-4. PubMed ID: 18796503
[No Abstract] [Full Text] [Related]
2. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.
Almendral J; Arribas F; Wolpert C; Ricci R; Adragao P; Cobo E; Navarro X; Quesada A; ; ;
Europace; 2008 May; 10(5):528-35. PubMed ID: 18390985
[TBL] [Abstract][Full Text] [Related]
3. To test or not to test during defibrillator implantation? A reassessment of the conventional wisdom.
Markowitz SM
J Cardiovasc Electrophysiol; 2008 Apr; 19(4):406-8. PubMed ID: 18298509
[No Abstract] [Full Text] [Related]
4. Is defibrillation testing still necessary? A decision analysis and Markov model.
Gula LJ; Massel D; Krahn AD; Yee R; Skanes AC; Klein GJ
J Cardiovasc Electrophysiol; 2008 Apr; 19(4):400-5. PubMed ID: 18298512
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter-defibrillators in patients with Chagas heart disease: misperceptions, many questions and the urgent need for a randomized clinical trial.
Rassi A
J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1241-3. PubMed ID: 17971129
[No Abstract] [Full Text] [Related]
6. Implantable cardioverter defibrillator efficacy and chronic kidney disease: competing risks of arrhythmic and nonarrhythmic mortality.
Goldenberg I; Moss AJ
J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1281-3. PubMed ID: 18775038
[No Abstract] [Full Text] [Related]
7. CRT-D therapy in heart failure: how much do NYHA class IV patients benefit?
Lehmann MH; Aaronson KD
J Cardiovasc Electrophysiol; 2006 May; 17(5):491-4. PubMed ID: 16684020
[No Abstract] [Full Text] [Related]
8. Early mortality in implantable cardioverter defibrillator patients: from randomized controlled trials to real life.
Köbe J; Eckardt L
Europace; 2009 Jun; 11(6):694-6. PubMed ID: 19470594
[No Abstract] [Full Text] [Related]
9. Jumping in before the water is hot: the need to support randomized controlled clinical trials.
Epstein AE
J Cardiovasc Electrophysiol; 2004 Aug; 15(8):867-9. PubMed ID: 15333076
[No Abstract] [Full Text] [Related]
10. Re: Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
Cardinalli-Neto A; Bestetti RB; Cordeiro JA
J Cardiovasc Electrophysiol; 2008 Apr; 19(4):E34-5. PubMed ID: 18298517
[No Abstract] [Full Text] [Related]
11. Does size really matter? A comparison of the Riata lead family based on size and its relation to performance.
Corbisiero R; Armbruster R
Pacing Clin Electrophysiol; 2008 Jun; 31(6):722-6. PubMed ID: 18507545
[TBL] [Abstract][Full Text] [Related]
12. What resides in T-wave residuum?
Moss AJ
J Cardiovasc Electrophysiol; 2005 Sep; 16(9):952-3. PubMed ID: 16174014
[No Abstract] [Full Text] [Related]
13. Simpler is better? Full circle in our attempt to decrease cardioverter defibrillator inappropriate shocks in the young.
Kugler JD
J Cardiovasc Electrophysiol; 2009 Mar; 20(3):291-2. PubMed ID: 19175844
[No Abstract] [Full Text] [Related]
14. Differences between women and men with ICDs: myth or reality?
Pelargonio G; Bisceglia C
J Cardiovasc Electrophysiol; 2009 Sep; 20(9):979-81. PubMed ID: 19563354
[No Abstract] [Full Text] [Related]
15. Do implantable cardioverter-defibrillators reduce the risk of death?
Manag Care Interface; 2005 Mar; 18(3):20. PubMed ID: 15816294
[No Abstract] [Full Text] [Related]
16. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
Stockburger M; Celebi O; Krebs A; Knaus T; Nitardy A; Habedank D; Dietz R
Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter-defibrillators and chronic kidney disease.
Saravanan P; Lang C; Davidson N
J Cardiovasc Electrophysiol; 2009 Mar; 20(3):E60; author reply E61. PubMed ID: 19271291
[No Abstract] [Full Text] [Related]
18. Time dependence of arrhythmias in ICD patients.
Faulknier B; Huang DT; Daubert JP
J Cardiovasc Electrophysiol; 2008 Aug; 19(8):790-3. PubMed ID: 18462331
[No Abstract] [Full Text] [Related]
19. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter defibrillators: do women fare worse than men? Gender comparison in the INTRINSIC RV trial.
Russo AM; Day JD; Stolen K; Mullin CM; Doraiswamy V; Lerew DL; Olshansky B
J Cardiovasc Electrophysiol; 2009 Sep; 20(9):973-8. PubMed ID: 19470037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
